Our Mission
The Society will strive to serve as the premier international multidisciplinary organization fostering and encouraging quality and innovation in clinical and basic research related to the etiology, diagnosis, treatment, and prevention of androgen excess disorders.
Promote excellence in basic and clinical research in androgen excess that improves the detection and treatment of these disorders.
Serve as a forum for the exchange of ideas between professionals from different scientific and clinical backgrounds, striving to stimulate evidence-based studies that guide the management of these disorders.
Educate research-sponsoring agencies in the U.S. and elsewhere, either alone or in partnership with patient groups, regarding the importance, priorities, and need for funding of studies of androgen excess disorders.
Provide a platform for investigators in search of collaborators, either for additional expertise or to aid in subject recruitment.
Produce and disseminate information regarding androgen excess disorders for patients and the general public.
Provide a forum for the collection and dissemination of recent findings in androgen excess research, either published or presented at meetings. Participate in evidence-based guidelines for screening, diagnosis, and treatment of androgen excess disorders.
Provide a forum for the direct exchange of ideas through the sponsorship or co-sponsorship of scientific meetings.
Androgen Excess and PCOS Society
The Androgen Excess and PCOS Society is an international organization dedicated to promoting the generation and dissemination of knowledge related to all aspects of androgen excess disorders including:
- Polycystic Ovary Syndrome
- Adrenal Hyperplasia
- Idiopathic Hirsutism
- Premature Adrenarche
Members include scientists and clinicians, whose major interests are the etiology, diagnosis, treatment, and prevention of androgen excess disorders. The Society disseminates information to both the medical and scientific community and the general public.

Our Vision
The Society will strive to serve as the premier international multidisciplinary organization fostering and encouraging quality and innovation in clinical and basic research related to the etiology, diagnosis, treatment, and prevention of androgen excess disorders.
- Promote excellence in basic and clinical research in androgen excess that improves the detection and treatment of these disorders.
- Serve as a forum for the exchange of ideas between professionals from different scientific and clinical backgrounds, striving to stimulate evidence-based studies that guide the management of these disorders.
- Educate research-sponsoring agencies in the U.S. and elsewhere, either alone or in partnership with patient groups, regarding the importance, priorities, and need for funding of studies of androgen excess disorders.
- Provide a platform for investigators in search of collaborators, either for additional expertise or to aid in subject recruitment.
- Produce and disseminate information regarding androgen excess disorders for patients and the general public.
- Provide a forum for the collection and dissemination of recent findings in androgen excess research, either published or presented at meetings.
- Participate in evidenced-based guidelines for screening, diagnosis, and treatment of androgen excess disorders.
- Provide a forum for the direct exchange of ideas through the sponsorship or co-sponsorship of scientific meetings.
Board of Directors

Kathleen Hoeger, M.D., M.P.H.
President
University of Rochester
Rochester, USA

Joop Laven, M.D., Ph.D.
President-Elect
Erasmus Medical Centre
Rotterdam, The Netherlands

Elisabet Victorin, Ph.D.
Past President
Karolinska Institutet
Stockholm, Sweden

Anuja Dokras, M.D., Ph.D.
Associate Executive Director
University of Pennsylvania
Philadelphia, USA

Tania Burgert, M.D.
Treasurer
University of Missouri-Kansas City School of Medicine
Kansas City, USA

Terhi Piltonen, M.D., Ph.D.
Director-at-Large
University of Oulu
Oulu, Finland

Poli Mara Spritzer, M.D., Ph.D.
Director-at-Large
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil

Anju Joham, Ph.D, MBBS, FRACP
Director-at-Large
Monash University
Melbourne, Australia

Rebecca Campbell
Director-at-Large
University of Otago
Dunedin, New Zealand
Committees Chairs

Elisabet Victorin, Ph.D.
Nominating Committee
Karolinska Institutet
Stockholm, Sweden

Joop Laven, M.D., Ph.D.
Publication Committee
Erasmus Medical Centre
Rotterdam, The Netherlands

Tania Burgert, M.D.
Website and Education/Advocacy Committee
University of Missouri-Kansas City School of Medicine
Kansas City, USA

Anuja Dokras, M.D., Ph.D.
Fundraising Committee
University of Pennsylvania
Philadelphia, USA

Marla Lujan, Ph.D.
Website Committee
Cornell University
Ithaca, USA

Rebecca Campbell
Annual Meeting Scientific Program Committee
Cedars-Sinai Medical Center - UCLA
Los Angeles, United States
Early Career Special Interest Group
The AEPCOS Early Career Special Interest Group (EC-SIG) is a forum for early career professionals to network and obtain professional development. Activities include quarterly conference calls and on-line meet the professor sessions as well as special networking events at scientific meetings. Early career professionals of the AEPCOS society are encouraged to participate in the Early Career Special Interest Group. Please contact the co-chairs below for more details.

Marla Lujan, Ph.D.
Faculty Lead
Cornell University
Ithaca, USA

Laura Cooney, M.D
Chair

Chau Thien Tay, BMedSc, MBBS (Hons), FRACP, Ph
Chair

Bassel H. Al Wattar, M.D., PGD, MRCOG, Ph.D.
Secretary
The University of Warwick
Coventry, United Kingdom